JP2015514751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015514751A5 JP2015514751A5 JP2015506529A JP2015506529A JP2015514751A5 JP 2015514751 A5 JP2015514751 A5 JP 2015514751A5 JP 2015506529 A JP2015506529 A JP 2015506529A JP 2015506529 A JP2015506529 A JP 2015506529A JP 2015514751 A5 JP2015514751 A5 JP 2015514751A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- soluble drug
- measured
- quinolin
- thiophen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 29
- 239000000203 mixture Substances 0.000 claims 17
- 229940079593 drug Drugs 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 16
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 claims 10
- 229960004372 aripiprazole Drugs 0.000 claims 10
- ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical compound C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 claims 10
- 239000000375 suspending agent Substances 0.000 claims 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 9
- 238000002360 preparation method Methods 0.000 claims 9
- 239000011164 primary particle Substances 0.000 claims 9
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- 239000007972 injectable composition Substances 0.000 claims 5
- 238000002347 injection Methods 0.000 claims 5
- 239000007924 injection Substances 0.000 claims 5
- 241001137251 Corvidae Species 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000002612 dispersion medium Substances 0.000 claims 3
- 229940071643 prefilled syringe Drugs 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000011163 secondary particle Substances 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261636938P | 2012-04-23 | 2012-04-23 | |
| US61/636,938 | 2012-04-23 | ||
| US201361792089P | 2013-03-15 | 2013-03-15 | |
| US61/792,089 | 2013-03-15 | ||
| PCT/JP2013/062683 WO2013162048A1 (en) | 2012-04-23 | 2013-04-23 | Injectable preparation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017206658A Division JP6470378B2 (ja) | 2012-04-23 | 2017-10-25 | 注射製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015514751A JP2015514751A (ja) | 2015-05-21 |
| JP2015514751A5 true JP2015514751A5 (enExample) | 2016-06-09 |
| JP6234996B2 JP6234996B2 (ja) | 2017-11-22 |
Family
ID=48614096
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015506529A Active JP6234996B2 (ja) | 2012-04-23 | 2013-04-23 | 注射製剤 |
| JP2017206658A Active JP6470378B2 (ja) | 2012-04-23 | 2017-10-25 | 注射製剤 |
| JP2019005031A Pending JP2019070028A (ja) | 2012-04-23 | 2019-01-16 | 注射製剤 |
| JP2020172902A Pending JP2021008512A (ja) | 2012-04-23 | 2020-10-14 | 注射製剤 |
| JP2022004098A Active JP7293412B2 (ja) | 2012-04-23 | 2022-01-14 | 注射製剤 |
| JP2023092924A Active JP7612758B2 (ja) | 2012-04-23 | 2023-06-06 | 注射製剤 |
| JP2024226861A Pending JP2025041805A (ja) | 2012-04-23 | 2024-12-24 | 注射製剤 |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017206658A Active JP6470378B2 (ja) | 2012-04-23 | 2017-10-25 | 注射製剤 |
| JP2019005031A Pending JP2019070028A (ja) | 2012-04-23 | 2019-01-16 | 注射製剤 |
| JP2020172902A Pending JP2021008512A (ja) | 2012-04-23 | 2020-10-14 | 注射製剤 |
| JP2022004098A Active JP7293412B2 (ja) | 2012-04-23 | 2022-01-14 | 注射製剤 |
| JP2023092924A Active JP7612758B2 (ja) | 2012-04-23 | 2023-06-06 | 注射製剤 |
| JP2024226861A Pending JP2025041805A (ja) | 2012-04-23 | 2024-12-24 | 注射製剤 |
Country Status (31)
| Country | Link |
|---|---|
| US (9) | US20150093442A1 (enExample) |
| EP (2) | EP2841054B2 (enExample) |
| JP (7) | JP6234996B2 (enExample) |
| KR (4) | KR20210116702A (enExample) |
| CN (3) | CN108186556B (enExample) |
| AR (1) | AR090776A1 (enExample) |
| AU (6) | AU2013253374B2 (enExample) |
| BR (1) | BR112014026307B1 (enExample) |
| CA (2) | CA2869889C (enExample) |
| CO (1) | CO7151500A2 (enExample) |
| CY (1) | CY1122252T1 (enExample) |
| DK (1) | DK2841054T4 (enExample) |
| EA (1) | EA026619B1 (enExample) |
| ES (1) | ES2743706T5 (enExample) |
| HR (1) | HRP20191366T4 (enExample) |
| HU (1) | HUE045979T2 (enExample) |
| IL (1) | IL235299B (enExample) |
| JO (2) | JOP20200109A1 (enExample) |
| LT (1) | LT2841054T (enExample) |
| MX (2) | MX359241B (enExample) |
| MY (3) | MY198007A (enExample) |
| NZ (1) | NZ630335A (enExample) |
| PH (2) | PH12014502379A1 (enExample) |
| PL (1) | PL2841054T5 (enExample) |
| PT (1) | PT2841054T (enExample) |
| SG (3) | SG10201913425VA (enExample) |
| SI (1) | SI2841054T2 (enExample) |
| TW (6) | TW202535396A (enExample) |
| UA (1) | UA115444C2 (enExample) |
| WO (1) | WO2013162048A1 (enExample) |
| ZA (1) | ZA201407335B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR090775A1 (es) * | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | Preparado inyectable |
| TWI562991B (en) * | 2012-04-23 | 2016-12-21 | Otsuka Pharma Co Ltd | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
| JOP20200109A1 (ar) * | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| CN105461703B (zh) * | 2014-12-29 | 2019-05-17 | 深圳市泛谷药业股份有限公司 | 一种brexpiprazole的制备方法 |
| JP6513461B2 (ja) * | 2015-04-14 | 2019-05-15 | 帝國製薬株式会社 | ブレクスピプラゾールの経皮吸収製剤 |
| CN104829603A (zh) * | 2015-05-19 | 2015-08-12 | 杭州新博思生物医药有限公司 | A晶型依匹唑派盐酸盐及其制备方法 |
| EP3411370A1 (en) * | 2016-02-01 | 2018-12-12 | Hexal AG | Anhydrate-free polymorphically pure micronized crystalline brexpiprazole dihydrate for use in intramuscular injectable sustained release formulations |
| WO2018137708A1 (zh) * | 2017-01-26 | 2018-08-02 | 重庆莱美药业股份有限公司 | 一种纳米炭-铁复合体系及其组合物、制备方法和用途 |
| WO2019213286A1 (en) * | 2018-05-02 | 2019-11-07 | LifeMax Laboratories, Inc. | Extended release suspension formulation of lurasidone |
| WO2020089942A2 (en) * | 2018-11-02 | 2020-05-07 | Amaterasu Lifesciences Llp | A liquid injectable composition |
| WO2021199076A1 (en) * | 2020-03-30 | 2021-10-07 | Cipla Limited | Injectable aripiprazole formulation |
| PL4125903T3 (pl) * | 2020-04-01 | 2025-02-03 | Otsuka Pharmaceutical Co., Ltd. | Sposoby rozpoczynania podawania leczenia arypiprazolem |
| US20230372317A1 (en) * | 2020-10-27 | 2023-11-23 | Pts Consulting, Llc | A liquid injectable composition of donepezil |
| US11229644B1 (en) * | 2020-12-31 | 2022-01-25 | Lake O'hara Llc | Methods of treating psychiatric disorders in obese patients with brexpiprazole |
| US11910794B2 (en) | 2021-03-08 | 2024-02-27 | Monsanto Technology Llc | Solutions and methods for long-term pollen storage |
| WO2023067664A1 (ja) * | 2021-10-18 | 2023-04-27 | 大塚製薬株式会社 | ベンゾチオフェン化合物の新規結晶形及びその製造方法 |
| US20250090476A1 (en) * | 2022-06-16 | 2025-03-20 | Wisdom Pharmaceutical Co., Ltd. | Pharmaceutical composition and brexpiprazole orally soluable film |
| CN115969785A (zh) * | 2022-12-30 | 2023-04-18 | 辰欣药业股份有限公司 | 一种阿立哌唑注射剂及其制备方法 |
| CA3197997A1 (en) * | 2023-03-17 | 2025-01-23 | Otsuka Pharmaceutical Co., Ltd. | METHODS FOR DISPERSING INJECTABLE PREPARATIONS OF ARIPIPRAZOLE |
| TW202448470A (zh) | 2023-04-26 | 2024-12-16 | 日商大塚製藥股份有限公司 | 用於以阿立哌唑治療思覺失調症或第一型雙極性疾患之劑量起始 |
| WO2025051281A1 (zh) * | 2023-09-08 | 2025-03-13 | 广州玻思韬控释药业有限公司 | 注射用依匹哌唑凝胶 |
| WO2025183016A1 (ja) * | 2024-02-26 | 2025-09-04 | 大塚製薬株式会社 | Ｑｕａｂｏｄｅｐｉｓｔａｔ含有組成物 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB864100A (en) * | 1957-04-09 | 1961-03-29 | Pfizer & Co C | Therapeutic pencillin compositions and the preparation thereof |
| JPS5913714A (ja) | 1982-07-13 | 1984-01-24 | Taito Pfizer Kk | 外用消炎鎮痛剤 |
| US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
| JP4012994B2 (ja) | 1996-05-08 | 2007-11-28 | 大塚製薬株式会社 | 抗不安薬 |
| WO2003030868A1 (en) | 2001-10-09 | 2003-04-17 | Bristol-Myers Squibb Company | Flashmelt oral dosage formulation |
| US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
| AR032641A1 (es) | 2001-01-29 | 2003-11-19 | Otsuka Pharma Co Ltd | Agonista de subtipo de receptor 5-ht 1a. |
| MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| PE20030445A1 (es) * | 2001-09-25 | 2003-07-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| JP2003171264A (ja) * | 2001-12-07 | 2003-06-17 | Taiyo Yakuhin Kogyo Kk | マイクロカプセル及びその製造方法 |
| JP2003238393A (ja) | 2002-02-15 | 2003-08-27 | Otsuka Pharmaceut Co Ltd | 施錠性が改善された錠剤及びその製造方法 |
| GEP20063996B (en) * | 2002-08-20 | 2006-12-11 | Bristol Myers Squibb Co | Aripiprazole complex formulation and use thereof |
| AU2003295235B2 (en) | 2002-12-27 | 2008-06-19 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| ATE308524T1 (de) | 2003-01-09 | 2005-11-15 | Otsuka Pharma Co Ltd | Verfahren zur herstellung von aripiprazole |
| US7658998B2 (en) | 2003-01-22 | 2010-02-09 | Alkermes Controlled Therapeutics, Inc. | Method of preparing sustained release microparticles |
| CA2523484A1 (en) * | 2003-05-02 | 2004-11-11 | Rimon Therapeutics Ltd. | Thermally reversible implant |
| CN1794994A (zh) | 2003-05-23 | 2006-06-28 | 大塚制药株式会社 | 用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂 |
| US6987111B2 (en) | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
| US20050032811A1 (en) | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
| CN1870980B (zh) | 2003-10-23 | 2010-06-23 | 大冢制药株式会社 | 控释无菌阿立哌唑注射剂和方法 |
| TWI371274B (en) | 2003-10-23 | 2012-09-01 | Bristol Myers Squibb Co | Process for making sterile aripiprazole of desired mean particle size |
| CA2543940A1 (en) | 2003-10-27 | 2005-05-19 | Dow Corning Corporation | Preparations for topical application and methods of delivering an active agent to a substrate |
| AU2005206143B2 (en) | 2004-01-12 | 2010-12-16 | The Trustees Of The University Of Pennsylvania | Long-term delivery formulations and methods of use thereof |
| JP2006219380A (ja) * | 2005-02-08 | 2006-08-24 | Minofuaagen Seiyaku:Kk | グリチルリチン皮下注射製剤 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| US20070148100A1 (en) | 2005-09-15 | 2007-06-28 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
| EP1948271B1 (en) | 2005-11-17 | 2013-10-02 | Zogenix, Inc. | Delivery of viscous formulations by needle-free injection |
| JP4373983B2 (ja) | 2006-01-27 | 2009-11-25 | 三菱電機インフォメーションシステムズ株式会社 | 流通経路管理装置及び流通経路管理プログラム |
| GB0618879D0 (en) * | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
| MX2009003735A (es) * | 2006-10-05 | 2009-04-22 | Panacea Biotec Ltd | Composicion en deposito inyectable y su procedimiento de preparacion. |
| JP4540700B2 (ja) | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | 医薬 |
| AU2007344864A1 (en) | 2007-01-26 | 2008-07-31 | Otsuka Pharmaceutical Co., Ltd. | Marker for detecting the proposed efficacy of treatment |
| CA2691597C (en) | 2007-06-25 | 2016-04-05 | Otsuka Pharmaceutical Co., Ltd. | Microspheres having core/shell structure |
| DK2170279T3 (en) | 2007-07-31 | 2018-03-12 | Otsuka Pharma Co Ltd | PROCEDURES FOR PREPARING AN ARIPIPRAZOL SUSPENSION AND A FREEZER DRIED FORMULATION |
| US20090258850A1 (en) * | 2007-08-21 | 2009-10-15 | Frincke James M | Stabilized therapeutic compositions and formulations |
| JP2011136906A (ja) * | 2008-04-18 | 2011-07-14 | Otsuka Pharmaceut Co Ltd | 複素環化合物 |
| JP2009286740A (ja) | 2008-05-30 | 2009-12-10 | Otsuka Pharmaceut Co Ltd | アリピプラゾールを含有する逆耐性抑制剤 |
| TR200809200A1 (tr) | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
| WO2010138539A2 (en) | 2009-05-27 | 2010-12-02 | Elan Pharma International Ltd. | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
| KR20160147061A (ko) | 2009-09-11 | 2016-12-21 | 오츠카 세이야쿠 가부시키가이샤 | 만성 동통 치료제 |
| RU2535089C2 (ru) * | 2010-08-24 | 2014-12-10 | Оцука Фармасьютикал Ко., Лтд. | Суспензия и затвердевшая композиция, содержащие производное карбостирила и силиконовое масло и/или производное силиконового масла |
| CA2814840C (en) * | 2010-10-18 | 2018-08-28 | Dainippon Sumitomo Pharma Co., Ltd. | Sustained-release formulation for injection |
| AR083884A1 (es) | 2010-11-16 | 2013-03-27 | Otsuka Pharma Co Ltd | Jeringa prellenable de doble camara y relleno de aripiprazol en la jeringa |
| JP2012121850A (ja) | 2010-12-09 | 2012-06-28 | Otsuka Pharmaceut Co Ltd | アリピプラゾールの経口速溶性組成物 |
| JP5980215B2 (ja) | 2011-01-24 | 2016-08-31 | 大塚製薬株式会社 | アリピプラゾールを有効成分とするケーキ状組成物が含有された医療用器具、及びアリピプラゾールを有効成分とするケーキ状組成物 |
| JOP20120083B1 (ar) | 2011-04-05 | 2021-08-17 | Otsuka Pharma Co Ltd | توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns |
| JP2012232958A (ja) † | 2011-05-09 | 2012-11-29 | Otsuka Pharmaceut Co Ltd | 注射製剤 |
| JO3410B1 (ar) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | تركيبة أريبيبرازول مجفف بالتبريد |
| WO2013000391A1 (zh) * | 2011-06-27 | 2013-01-03 | 上海中西制药有限公司 | 一种阿立哌唑药物制剂及其制备方法 |
| TW201309651A (zh) | 2011-06-29 | 2013-03-01 | Otsuka Pharma Co Ltd | 阿立哌唑（ａｒｉｐｉｐｒａｚｏｌｅ）無水物Ｂ形結晶微粒子之製造方法 |
| EP2736894B1 (en) | 2011-07-28 | 2016-08-31 | Otsuka Pharmaceutical Co., Ltd. | Method for producing benzo[b] thiophene compounds |
| JO3227B1 (ar) | 2011-09-08 | 2018-03-08 | Otsuka Pharma Co Ltd | مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان |
| JO3753B1 (ar) | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
| TWI679977B (zh) | 2011-10-19 | 2019-12-21 | 大塚製藥股份有限公司 | 口服溶液 |
| JP2013139441A (ja) | 2011-12-28 | 2013-07-18 | Otsuka Pharmaceut Co Ltd | マイクロスフェア |
| TW201332572A (zh) | 2011-12-28 | 2013-08-16 | Otsuka Pharma Co Ltd | 具有經取代的β－環糊精之藥物製劑 |
| TW201343201A (zh) | 2012-03-06 | 2013-11-01 | Otsuka Pharma Co Ltd | 持續釋放型口服固體製劑 |
| TWI562991B (en) | 2012-04-23 | 2016-12-21 | Otsuka Pharma Co Ltd | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| AR090775A1 (es) | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | Preparado inyectable |
-
2012
- 2012-04-23 JO JOP/2020/0109A patent/JOP20200109A1/ar unknown
-
2013
- 2013-04-22 AR ARP130101321A patent/AR090776A1/es not_active Application Discontinuation
- 2013-04-23 JP JP2015506529A patent/JP6234996B2/ja active Active
- 2013-04-23 SG SG10201913425VA patent/SG10201913425VA/en unknown
- 2013-04-23 PL PL13728542.5T patent/PL2841054T5/pl unknown
- 2013-04-23 HR HRP20191366TT patent/HRP20191366T4/hr unknown
- 2013-04-23 CA CA2869889A patent/CA2869889C/en active Active
- 2013-04-23 SG SG11201406451SA patent/SG11201406451SA/en unknown
- 2013-04-23 WO PCT/JP2013/062683 patent/WO2013162048A1/en not_active Ceased
- 2013-04-23 CN CN201810143716.5A patent/CN108186556B/zh active Active
- 2013-04-23 KR KR1020217029406A patent/KR20210116702A/ko not_active Ceased
- 2013-04-23 CN CN201380021440.9A patent/CN104470499B/zh active Active
- 2013-04-23 DK DK13728542.5T patent/DK2841054T4/da active
- 2013-04-23 KR KR1020147032714A patent/KR102138852B1/ko active Active
- 2013-04-23 ES ES13728542T patent/ES2743706T5/es active Active
- 2013-04-23 MY MYPI2018001894A patent/MY198007A/en unknown
- 2013-04-23 TW TW113144877A patent/TW202535396A/zh unknown
- 2013-04-23 CA CA3120297A patent/CA3120297A1/en active Pending
- 2013-04-23 UA UAA201411954A patent/UA115444C2/uk unknown
- 2013-04-23 JO JOP/2013/0116A patent/JO3632B1/ar active
- 2013-04-23 PT PT13728542T patent/PT2841054T/pt unknown
- 2013-04-23 HU HUE13728542A patent/HUE045979T2/hu unknown
- 2013-04-23 MX MX2014012811A patent/MX359241B/es active IP Right Grant
- 2013-04-23 BR BR112014026307-8A patent/BR112014026307B1/pt active IP Right Grant
- 2013-04-23 AU AU2013253374A patent/AU2013253374B2/en active Active
- 2013-04-23 SG SG10201608753UA patent/SG10201608753UA/en unknown
- 2013-04-23 EP EP13728542.5A patent/EP2841054B2/en active Active
- 2013-04-23 TW TW111116460A patent/TW202313036A/zh unknown
- 2013-04-23 TW TW107109282A patent/TWI713826B/zh active
- 2013-04-23 CN CN202210169142.5A patent/CN114344259B/zh active Active
- 2013-04-23 MY MYPI2014002932A patent/MY178573A/en unknown
- 2013-04-23 TW TW109130917A patent/TW202126303A/zh unknown
- 2013-04-23 KR KR1020207015451A patent/KR102498075B1/ko active Active
- 2013-04-23 US US14/396,380 patent/US20150093442A1/en not_active Abandoned
- 2013-04-23 MY MYPI2023004225A patent/MY210484A/en unknown
- 2013-04-23 LT LTEP13728542.5T patent/LT2841054T/lt unknown
- 2013-04-23 SI SI201331550T patent/SI2841054T2/sl unknown
- 2013-04-23 EP EP19169193.0A patent/EP3539534A1/en active Pending
- 2013-04-23 NZ NZ630335A patent/NZ630335A/en unknown
- 2013-04-23 KR KR1020247015029A patent/KR20240068788A/ko not_active Ceased
- 2013-04-23 MX MX2018010879A patent/MX387891B/es unknown
- 2013-04-23 TW TW112130297A patent/TW202425992A/zh unknown
- 2013-04-23 TW TW102114410A patent/TWI637752B/zh active
- 2013-04-23 EA EA201491685A patent/EA026619B1/ru not_active IP Right Cessation
-
2014
- 2014-10-09 ZA ZA2014/07335A patent/ZA201407335B/en unknown
- 2014-10-23 PH PH12014502379A patent/PH12014502379A1/en unknown
- 2014-10-23 IL IL235299A patent/IL235299B/en active IP Right Grant
- 2014-11-21 CO CO14256422A patent/CO7151500A2/es unknown
-
2017
- 2017-09-11 US US15/701,202 patent/US20180055941A1/en not_active Abandoned
- 2017-09-14 AU AU2017228608A patent/AU2017228608C1/en active Active
- 2017-10-25 JP JP2017206658A patent/JP6470378B2/ja active Active
-
2018
- 2018-10-10 US US16/156,958 patent/US10517951B2/en active Active
-
2019
- 2019-01-07 AU AU2019200060A patent/AU2019200060A1/en not_active Abandoned
- 2019-01-16 JP JP2019005031A patent/JP2019070028A/ja active Pending
- 2019-03-07 PH PH12019500498A patent/PH12019500498A1/en unknown
- 2019-07-17 US US16/514,973 patent/US20190336607A1/en not_active Abandoned
- 2019-08-28 CY CY20191100912T patent/CY1122252T1/el unknown
-
2020
- 2020-02-07 US US16/785,268 patent/US20200179517A1/en not_active Abandoned
- 2020-06-24 AU AU2020204200A patent/AU2020204200B2/en active Active
- 2020-10-14 JP JP2020172902A patent/JP2021008512A/ja active Pending
- 2020-12-01 US US17/108,939 patent/US11097007B2/en active Active
-
2021
- 2021-08-04 US US17/444,469 patent/US11638757B2/en active Active
-
2022
- 2022-01-14 JP JP2022004098A patent/JP7293412B2/ja active Active
- 2022-09-27 AU AU2022241491A patent/AU2022241491B2/en active Active
- 2022-12-30 US US18/148,860 patent/US12016927B2/en active Active
-
2023
- 2023-06-06 JP JP2023092924A patent/JP7612758B2/ja active Active
-
2024
- 2024-05-13 US US18/662,049 patent/US20250121065A1/en active Pending
- 2024-12-24 JP JP2024226861A patent/JP2025041805A/ja active Pending
-
2025
- 2025-01-13 AU AU2025200229A patent/AU2025200229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015514751A5 (enExample) | ||
| JP2018048179A5 (enExample) | ||
| HRP20191366T1 (hr) | Injekcijski pripravak | |
| JP2013525493A5 (enExample) | ||
| JP2014240439A5 (enExample) | ||
| JP6094388B2 (ja) | ペメトレキセドを含む注射用組成物 | |
| TW201141524A (en) | Stabilized ophthalmic galactomannan formulations | |
| JP2017525671A5 (enExample) | ||
| JP2017513925A (ja) | 徐放性ブプレノルフィン溶液 | |
| JP2016539921A5 (enExample) | ||
| CN103491961B (zh) | 阿立哌唑组合物和用于其经皮给药的方法 | |
| CN103816111A (zh) | 一种罗哌卡因纳米脂质载体温敏原位凝胶及其制备方法 | |
| JP2014530801A5 (enExample) | ||
| RU2013130224A (ru) | Фармацевтические композиции | |
| RU2017108204A (ru) | Композиции пролекарства арипипразола | |
| RU2017129375A (ru) | Интестинальный гель на основе леводопы и карбидопы и способы его применения | |
| CN104507467A (zh) | 含紫杉烷系活性成分的液体组合物、其制造方法及液体制剂 | |
| JP2015519398A5 (enExample) | ||
| JP5872551B2 (ja) | パラセタモールを含む医薬組成物およびその製造法 | |
| CN103550150B (zh) | 改进的含二甲基硅油的注射剂 | |
| RU2013147613A (ru) | Местное дезинфицирующее средство, содержащее йод, обладающее низким содержанием поверхностно-активного вещества | |
| WO2016008289A1 (zh) | 一种盐酸伊立替康纳米脂束制剂及其制备方法 | |
| CN103550149A (zh) | 含抗寄生虫药物长效注射剂的制备技术 | |
| JP5535900B2 (ja) | ガチフロキサシン含有水性液剤、その製造方法、および、該水性液剤の低温保存および凍結融解時の沈殿生成を抑制する方法 | |
| JPWO2009123099A1 (ja) | ガチフロキサシン含有水性液剤 |